Skip to main content

Roche builds “best research center in the world”

Mock up Roche buildings at Grenzacherstrasse
| News

Roche builds “best research center in the world”


The pharmaceutical giant Roche has officially started building its new research center in Basel. Around 1,800 researchers should be able to work there by the end of 2023.

Mock up Roche buildings at Grenzacherstrasse
This is what Roche's new research center will look like (Visualization: Roche)

Roche has laid the foundation for its new research center (pRED Innovation Center) in Basel. A state-of-the-art laboratory and office environment will be completed by the end of 2023 at the company headquarters, providing space for about 1,800 researchers.

According to Roche’s own information, it is investing CHF 3 billion in development at the Basel site overall. From this, around CHF 1.2 billion will be put towards the new research center alone, which will comprise four new buildings. This investment is said to be a clear commitment to Switzerland as a location for research and business. Jürg Erismann, Head of the Basel/Kaiseraugst site at Roche, is quoted in an article by SRF, saying: “We are building the best research center in the world.” In the press release from Roche, he adds that the work environment being created can adapt to the changing requirements of the research division and digitization.

Sustainability is particularly important in constructing the new buildings; for instance, recycled concrete is being used to create the shell. Solar power systems will also be installed on the roofs of two buildings.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

The power of a persuasive pitch deck

Are you an entrepreneur striving to secure investment for your biotech startup? Start with an effective pitch deck to catch...
Read More

Roche investing an additional 1.2 billion Swiss francs in Basel

Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment...
Read More

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

How to access the U.S. market with your medical device

In one of our latest Venture Mentoring events by Basel Are Business & Innovation, we invited Nila-Pia Rähle to speak...
Read More

Do you have a question? We'd like to hear from you.